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Abstract: The metabolic syndrome is described by the clustering of several risk factors for cardiovascular
disease. This study aimed to assess the metabolic syndrome among Fars ethnic women in Gorgan, Capital City
of Golestan province, North East of Iran. The study conducted on the hundred and sixty Fars women (20-
40years) who were referred to the Health Centers in Gorgan. Metabolic syndrome was diagnosed using Adult
Treatment Panel-III (ATP-III) guidelines. The mean triglyceride, total cholesterol, waist circumferences and
fasting blood glucose levels were significantly higher in the subjects with metabolic syndrome, but the mean
HDL-cholesterol was lower (p< 0.05). The prevalence of metabolic syndrome was 20.62%. High abdominal
obesity and low HDL-cholesterol level are the most frequent characteristics in comparison to other metabolic
components. According to our results, 13.75%, 5.62%and 1.25% had three, four and five criteria for metabolic
syndrome, respectively. Low HDL-cholesterol and high waist circumference were the most usual factors of
metabolic abnormality among women. Prevalence of cardiovascular diseases might be increased. We have
shown some related factors of metabolic syndrome in these women to predict metabolic syndrome in these
ethnic groups and help to prevent cardiovascular disease.
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INTRODUCTION concept of Syndrome X for the clustering of
The prevalence of the metabolic syndrome is intolerance, high triglycerides and low high density
increased generously by the epidemic increase of obesity lipoprotein (HDL) concentration [4]. The syndrome has
whole around the world. The metabolic syndrome is been given several names, including the 'metabolic
described by the clustering of several risk factors for syndrome', the 'insulin resistance syndrome', the
cardiovascular disease (CVD) such as hypertension, 'plurimetabolic syndrome' and the 'deadly quartet' [4]. In
dyslipidaemia, obesity (particularly central obesity), 1998, world health organization (WHO) proposed a
insulin resistance and high fasting plasma glucose [1] unifying definition for the syndrome and chose to call it
Metabolic syndrome was initially observed in 1923 by the 'metabolic syndrome' rather than the 'insulin resistance
Kyln [2], who described the clustering of hypertension, syndrome' [5]. This name was selected primarily because
hyperglycemia and gout as the syndrome. Subsequently, it was the cause of all the components of the syndrome.
several other metabolic abnormalities have been In 2001, the Third Report of National Cholesterol
associated with this syndrome, including obesity, Education Program Expert Panel on Detection, Evaluation
microalbuminuria and abnormalities in fibrinolysis and and Treatment of High Blood Cholesterol in Adults (Adult
coagulation [3]. In 1988, Gerald Reaven reintroduced the Treatment Panel III) (ATP III) emphasized the importance
cardiovascular risk factors like hypertension, glucose
World J. Med. Sci., 7 (1): 17-22, 2012
18
of the metabolic syndrome and provided a working Abdominal Obesity: Waist Circumference >88 cm 
definition of this syndrome for the first time [6].
Differences in genetic background, diet, levels of physical Hypertriglyceridaemia: Serum triglycerides level > 150
activity, age and sex structure all influence the prevalence mg/dl
of both metabolic syndrome and its components [7]. The
prevalence of metabolic syndrome in adult population Low HDL-Cholesterol: < 50 mg/dl
worldwide varies from 8 to 24.2% [8,9] in males and from
7 to 46.5% [10,11] in females. The importance of the High Blood Pressure: SBP > 130 mmHg and/or DBP > 85
metabolic syndrome in general populations as a predictor mmHg or on treatment for hypertension.
of vascular disease has been confirmed by a number of
large prospective epidemiologic studies [12-14]. In the High Fasting Glucose: Serum glucose level > 110 mg/dl or
United States, the metabolic syndrome has become on treatment for diabetes.
common [9]. Some studies show about increasing
prevalence of metabolic syndrome in Asia [15]. In our Weight was then measured, while subjects were
area, we do not have enough data on the adult women minimally clothed without shoes, using digital scales.
metabolic syndrome in Gorgan (South East of Caspian Height was measured in standing position using tape
Sea), Iran. Therefore, it is very important to set up a study meter while the shoulder was in a normal position. Body
on women with a risk of metabolic syndrome. The present mass index (BMI) was calculated as weight in kilograms
study aimed to assess the metabolic syndrome among divided by height in meters squared. Those with a BMI of
Fars women in this area. 25.0-29.9 Kg/m  were classified as overweight, whilst
MATERIALS AND METHODS Subjects with BMI greater than 45 Kg/m2 were considered
This cross sectional study was performed in the point halfway between the lower border of ribs and the
Biochemistry and Metabolic Disorders Research Center of iliac crest in a horizontal plane [17]. Systolic and diastolic
Gorgan, Golestan province (South East of Caspian Sea, blood pressure was measured in sitting position from the
North East of Iran) in 2011. The study group included 160 right hand. The results were reported as percentages and
Fars adult women (women who speak only Persian mean ± SD. The statistical analysis was done with SPSS-
language) who were referred to the different Health 16 version software. The results were evaluated by using
Centers in Gorgan. All the included subjects provided an independent student t and Chi square tests. Statistical
informed consent. Data were collected by trained significance was considered at P < 0.05.
interviewers. First of all, a questionnaire was completed at
each Health Center by trained interviewers. Demographic RESULTS
information is achieved by a questionnaire. The exclusion
criterion was the coexistence of any other serious illness. A total of hundred and sixty Fars women (Women
Exclusion criteria included having hormone replacement who speak only Persian (Farsi) language) were studied.
therapy, taking drugs such as anti-diabetes and anti- The mean age of the subjects was 53.65±9.50 years (range
hypertensive anti-lipidemic agents and smokers. A 20-40 years). Table 1 shows the baseline data of the
venous blood sample was collected from all the subjects subjects with and without the metabolic syndrome. The
who came after 8-12-hours in the morning after an mean triglyceride, total cholesterol and fasting blood
overnight fast. The samples were centrifuged for 10 glucose levels were significantly higher in the subjects
minutes at 3000 rpm. The serum was used for estimating with metabolic syndrome, but the mean HDL-cholesterol
fasting blood glucose, triglycerides, total cholesterol, was lower (p< 0.05). There were significant differences in
LDL-cholesterol and HDL-cholesterol concentrations, by the waist circumferences of subjects with the metabolic
biochemical kit using spectrophotometer techniques syndrome. There were no significant differences in the
(Model JENWAY 6105 UV / VIS) in the Biochemistry and other parameters in subjects with and without the
Metabolic Disorders Research Center (Gorgan Faculty of metabolic syndrome. Table 2 shows prevalence of
Medicine). Adult women considered to have metabolic metabolic syndrome and the components of metabolic
syndrome if they had any three or more of the following, syndrome in Fars ethnic group. The frequency of
according to the ATP III Criteria: [6] metabolic  syndrome   was   20.62%.   The   prevalence  of
2
those with a BMI• 30 Kg/m2 were defined as obese.
very obese [16]. Waist circumference was measured at the
World J. Med. Sci., 7 (1): 17-22, 2012
19
Table 1: Baseline data of Fars women (Total subjects, subjects with and without metabolic syndrome).
Total number Subjects with Subjects without
Parameters of subjects metabolic syndrome metabolic syndrome P-value
All women, No. (%) 160 (100) 33 (20.62) 127(79.38) -
Age (years) 32.54±6.54 34.06±5.09 32.07±6.81 0.07
BMI, kg/m 27.03±5.32 28.63±4.96 26.61±5.35 0.0522
WC, cm 93.98±13.12 99.89±9.14 92.44±13.59 <0.0001
SBP, mmHg 112.61±14.53 114.85±15.43 112.03±14.29 0.323
DBP, mmHg 69.91±10.51 70.30±10.95 69.81±10.43 0..815
FBS, mg/dl 110.18±61.14 150.2±101.69 88.43±36.03 0.002
TG, mg/dl 113.99±73.38 220.64±82.74 86.27±36.10 <0.0001
T-Chol, mg/dl 182.03±56.33 219.71±49.80 177.07±54.73 0.029
HDL-Chol, mg/dl 44.0±13.39 38.22±16.24 45.50±12.18 0.005
LDL-Chol, mg/dl 116.21±39.51 116.69±35.33 116.08±30.66 0.933
BMI: Body mass index, WC: waist circumference, WHR: waist to hip ratio, SBP: systolic blood pressure, DBP: diastolic blood pressure, FBS: fasting blood
glucose, TG: triglyceride, T-CHOL: total cholesterol, HDL-CHOL: HDL-cholesterol and LDL-CHOL: LDL-cholesterol
*P value less than 0.05 was considered significant.
Table 2: Prevalence of metabolic syndrome and the components of metabolic syndrome in Fars women (n=160)
Number %
Metabolic syndrome 33 20.62
Fasting Blood Sugar >110 mg/dl 23 14.30
High Density Lipoprotein-cholesterol < 50 mg/dl 47 29.37
Triglyceride > 150 mg/dl 32 20
Waist circumference > 88 cm 55 34.37
Systolic blood pressure >130 mmHg/ Diastolic blood pressure>85 mmHg 5 3.12
Table 3: Distribution of Fars women with and without metabolic syndrome
by age 
Subjects with Subjects without
Age groups in years MS(n=33) MS( n=127)
20-24 n (%) 1 (3.03) 25 (19.68)
25-29 n (%) 6 (18.18) 26 (20.47)
30-34 n (%) 8 (24.24)* 14 (11.02)
35-40 n (%) 18(54.54) 62 (48.81)
MS: Metabolic Syndrome
*P value less than 0.05 was considered significant.
Table 4: Number of subjects accomplishing the criteria of metabolic
syndrome
Parameters Subjects(n=160)
3 criteria n (%) 22 (13.75)
4 criteria n (%) 9(5.62)
5 criteria n (%) 2(1.25)
Total criteria n (%) 33(20.62)
central obesity, high triglyceride level, low High Density
Lipoprotein-cholesterol level, high blood pressure and
high fasting glucose were 34.37%, 20%, 29.37%, 3.12%
and 14.30%, respectively. Low HDL-cholesterol level
(29.37%) and high abdominal obesity (34.37%) are the
most frequent characteristics in comparison to other
metabolic components. Table 3 shows Fars women with
and without metabolic syndrome by the age. The most
age distribution was in ages between 35-40 years. The
prevalence of metabolic syndrome was the highest in ages
35-40 years. There was increased frequency of metabolic
syndrome from age 25-29 years in Fars women. The
prevalence of metabolic syndrome was high in ages 30-34
years when compared subjects with and without
metabolic syndrome. Table 4 shows number of subjects
accomplishing the criteria of metabolic syndrome.
According to our results, 13.75%, 5.62%and 1.25% had
three, four and five criteria for metabolic syndrome,
respectively. 
DISCUSSION
This study shows that 20.62% of this population has
metabolic syndrome. Differences in the prevalence of
metabolic syndrome can result from different
interpretation of the syndrome, sociological and
environmental, genetic factors and life style. Study in Italy
showed that a prevalence of metabolic syndrome was 3-
3.5% (on the basis of the presence of all five criteria) [18].
Studies among Korean and Chinese populations showed
that prevalence of metabolic syndrome were 13.8% [19]
and 17.8% for females, respectively [20]. Eshtiaghi et al.
showed that prevalence of metabolic syndrome was 18.3%
[21]. In our study the prevalence of the metabolic
syndrome is higher than some other studies were done in
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Italy, Korea, China and Iran [18-21], but our study is not related  factors of metabolic syndrome in these women to
in agreement with the studies were done by Ainy [22], predict metabolic syndrome in these ethnic groups and
Deilbert [23], Figueiredo Neto  and Heidari et al [25]. help to prevent cardiovascular disease.[24]
They have shown that prevalence of metabolic syndrome
were 53%, 23%, 24% and 449%, respectively. Studies in ACKNOWLEDGMENTS
Greece and USA have shown that prevalence of metabolic
syndrome was similar in both genders [26, 9]. Some other This study  was  supported   by  Golestan
studies in Turkey, India, Iran, African Americans, Mexican University of Medical Sciences. We thank all our
Americans have shown that women to be much more colleagues in the Department of Biochemistry,
frequently affected [9, 27], while in France and Australia Biochemistry and Metabolic Disorders Research Center
the metabolic syndrome was found to be more common and Health Centers.
among men [27]. Study on the components of metabolic
syndrome showed that the most frequent changes of Competing Interest: The authors have no conflicts of
components of metabolic syndrome was abdominal interest.
obesity (frequency of 34.37%), which is not in agreement
with the findings in USA [28], Turkey [29], Italy [30], Funding: The study was funded by research deputy of
Canada [31], UK [32] and Iranian population [33-34] that Golestan University of Medical Science
the most common found was high prevalence of low HDL-
cholesterol. Some studies have reported that waist REFERENCES
circumference is positively associated with the risk of
cardiovascular  occurrences  [35-36].  Study  of  Despres 1. Miranda,  P.J.,  R.A.  DeFronzo,  R.M.  Califf   and
et al showed that extra fat mass rather than excess body J.R. Guyton, 2005. Metabolic syndrome: definition,
weight  was  highly  correlated  with  abnormal metabolism pathophysiology  and  mechanisms.  Am  Heart  J.,
[37]. Our study showed that women with metabolic 149: 33-45.
syndrome had high abdominal obesity. Our results 2. Kylin, E., 1923. Studien ueber das Hypertonie-
showed that waist circumference was elevated among Hyperglykamie-Hyperurikamiesyndrom. Zentrallblatt
Fars women with metabolic syndrome. It was been also fuer Innere Medizin, 44: 105-27.
shown that women were overweight. Changes in central 3. Isomaa, B., P. Almgren, T. Tuomi, B. Forsen, K. Lahti
obesity can cause metabolism abnormality and influence M. Nissen, et al., 2001. Cardiovascular morbidity
health [38]. It is important to reduce the risk of and mortality associated with the metabolic
cardiovascular disease among these women. It suggests syndrome. Diabetes Care, 24: 683-9.
that among women with metabolic syndrome, blood 4. Reaven, G.M. and Banting Lecture 1988. Role of
glucose and blood lipid profile monitoring and changing insulin  resistance   in   human   disease.   Diabetes,
their life style leading to weight loss by diet and sport 37: 1595-607.
[25].  D espite   lifestyle  changes  such  as  an  increas e 5. Alberti, K.G. and P.Z. Zimmet, 1998. Definition,
in high-fat,   high-carbohydrate   intake   and  a  decrease diagnosis and classification of diabetes mellitus and
in physical activity due to economical alterations in Iran, its complications. Part I: diagnosis and classification
the metabolic syndrome in women remain an important of diabetes mellitus, provisional report of a WHO
problem. Study has been shown that 76.3% of females in Consultation. Diabet Med., 15: 539-53.
Iran had physical inactivity [39]. Iranian women mostly do 6. Expert Panel on Detection, Evaluation and Treatment
less physical activity and overweight and obesity are of High Blood Cholesterol in Adults. Executive
more common between them [40]. The reasonable Summary of The Third Report of The National
interpretation for our results is that Fars women in this Cholesterol Education Program (NCEP) Expert Panel
area maybe had lower physical activity. Our study has on Detection, Evaluation and Treatment of High
shown the prevalence of metabolic syndrome and the Blood Cholesterol in Adults Adult Treatment Panel
components of metabolic syndrome in Fars ethnic women III). JAMA, 2001. 285: 2486-97.
in Gorgan. Low HDL-cholesterol and high waist 7. Cameron, A.J., J.E. Shaw  and  P.Z.  Zimmet,  2004.
circumference were the most usual factors of metabolic The metabolic syndrome: prevalence in worldwide
abnormality among women. Prevalence of cardiovascular populations.   Endocrinol    Metab.    Clin.    N.
diseases might be increased. We have shown some Am., 33: 351-75.
World J. Med. Sci., 7 (1): 17-22, 2012
21
8.  Gupta,   A.,   R.   Gupta,   M.   Sarna,   S.   Rastogi, 17. Dalton,  M., A.J. Cameron, P.Z. Zimmet, J.E. Shaw,
V.P. Grupta and K. Kothari, 2003. Prevalence of D.D.  Jolley,  D.W.  Dunstan and T.A. Welborn,
diabetes, impaired fasting glucose and insulin 2003. AusDiab Steering Committee. Waist
resistance syndrome in an urban Indian population. circumference, waist-hip ratio and body mass index
Diabetes Res. Clin. Pract, 61: 69-76. and their correlation with cardiovascular disease risk
9. Ford, E.S., W.H. Giles and W.H. Dietz, 2002. factors  in   Australian   adults.   J.   Intern  Med.,
Prevalence of the metabolic syndrome among US 254: 555-63.
adults:  findings  from  the  Third  National  Health 18. Trevisan, M., J. Liu, F.B. Bahsas and A. Menotti,
and   Nutrition    Examination     Survey.   JAMA, 1998.   “Syndrome    X   and   mortality: a
287: 356-9. population-based study. Risk Factor and Life
10. Balkau,  B.,  M.   Vernay,   L.   Mhamdi,   M.  Novak, Expectancy Research Group,” American J.
D. Arondel, S. Vol, et al., 2003. The D.E.S.I.R Study Epidemiol., 10: 958 966. 
Group. The incidence and persistence of the NCEP 19.  Kim, H.M., J. Park, S.Y. Ryue and J. Kim, 2007. The
(National Cholesterol Education Program) metabolic effect of menopause on the metabolic syndrome
syndrome. The French D.E.S.I.R. study. Diabetes among Korean women. The Korean National Health
Metab, 29: 526-32. and Nutrition Examination Survey, 2001. Diabetes
11. Ramachandran,  A.,  C.   Snehalatha,  K.  Satyavani, Care, 30: 701-6.
S. Sivasankariand and V. Vijay, 2003. Metabolic 20. Gu, D., K. Reynolds, X. Wu et al., 2005 “Prevalence
syndrome in urban Asian Indian Adults-a of the metabolic syndrome and overweight among
population study using modified ATP III criteria. adults in China,” The Lancet, 9468: 1398-1405.
Diabetes Res. Clin Pract, 60: 199-204. 21. Eshtiaghi, R., A. Esteghamati and M. Nakhjavani,
12. Shepherd,  J.,  S.M.  Cobbe,  I.  Ford,   C.G.  Isles, 2010. Menopause is an independent predictor of
A.R. Lorimerand Mac P.W. Farlane, et al, 1995. metabolic  syndrome in Iranian women. Matutritas,
Prevention of coronary heart disease with 65: 262-266.
pravastatin in men with hypercholesterolemia. West 22. Ainy, E., P. Mirmiran, S. Zahedi Asl and F. Azizi,
of Scotland Coronary Prevention Study Group. N. 2007. Prevalence of metabolic syndrome during
Engl. J. Med., 333: 1301-7. menopausal transition Tehranian women. Tehran
13. Downs,  J.R.,  M. Clearfield, S. Weis, E .Whitney, Lipid  and   Glucose   Study    (TLGS).   Matutritas,
D.R. Shapiroand PA. Beerc, et al, 1998. Primary 58: 150-5.
prevention of acute coronary events with lovastatin 23. Deibert, P., D. Konig, M.Z. Vitolins, U.   Landmann,
in men and women with average cholesterol levels: I. Frey, Zahradnik, et al., 2007. effect of weight loss
results of AFCAPS/ TexCAPS. Air Force/Texas intervention on anthropometric measures and
Coronary Atherosclerosis Prevention Study. JAMA, metabolic risk factors in pre- versus postmenopausal
279: 1615-22. women. Nutr. J., 6: 31.
14. Ballantyne,   C.M.,    A.G.    Olsson,    T.J.    Cook, 24. Figueiredo Neto, J.A., E.D. Figueredo, E.D. Barbosa,
M.F. Mercuri, TR. Pedersen and J. Kjekshus, 2001. F. Barbosa Fde, G.R. Costa and V.J. Nina et al., 2010.
Influence of low high-density lipoprotein cholesterol Metabolic syndrome and menopause: Cross-
and elevated triglyceride on coronary heart disease sectional study in Gynecology clinic. Arq. Bras.
events and response to simvastatin therapy in 4S. Cardiol, 95: 339-45.
Circulation, 104: 3046-51. 25. Heidari,  R.,  M.  Sadeghi,   M.   Talaei, K.    Rabiei,
15. Meigs, J.B., 2000. “Invited commentary: insulin N. Mohammadifard and N. Sarrafzadegan, 2010.
resistance syndrome? Syndrome X? Multiple Metabolic syndrome in menopausal transition:
metabolic syndrome? A syndrome at all? Factor Isfahan Healthy Heart Program, a population based
analysis reveals patterns in the fabric of correlated study. Diabetol Metab. Syndr, 2: 59. 
metabolic risk factors,” American Journal of 26. Athyros,   V.G.,    E.S.   Ganotakis,   M.   Bathianaki,
Epidemiology, 10: 908-912. I. Monedas, I.A. Goudevenos,  A.A.  Papageorgiou,
16. World Health Organization. Prevention and et al., 2005. MetS-Greece Collaborative Group.
Management of the Global Epidemic of Obesity. Awareness, treatment and control of the metabolic
Report of the WHO Consultation on Obesity. WHO: syndrome and its components: a multicentre Greek
Geneva, 1998 (Technical Report Series, No. 894). study. Hellenic J. Cardiol., 46(6): 380-386.
World J. Med. Sci., 7 (1): 17-22, 2012
22
27. Cameron, A.J., J.E. Shaw and  P.Z.  Zimmet,  2004. 34. Azizi, F., A. Esmaillzadeh and P. Mirmiran, 2004.
The metabolic syndrome: prevalence in worldwide “Obesity and cardiovascular disease risk factors in
populations. Endocrinology and metabolism clinics Tehran adults: a populationbased study,” Eastern
of  North  America.   Metabolic   Syndrome:  Part 1, Mediterranean Health J., 6: 887-897.
33: 351-376. 35. De Koning, L., A.T. Merchant,  J.  Pogueand  and
28. Heiss, G., I. Tamir, C.E. Davis, et al., 1980. S.S. Anand, 2007. Waist circumference and waist-to-
“Lipoprotein-cholesterol distributions in selected hip ratio as predictors of cardiovascular events:
North American populations: the lipid research meta-regression analysis of prospective studies.
clinics   program    prevalence   study,”  Circulation, Eur. Heart J., 28: 850-6.
2: 302-315. 36. Hu,  G.,  J.  Tuomilehto,  K.   Silventoinen,   C.  Sarti,
29. Onat, A., G. Surdum-Avci, M. Senocak, E. Ornek and S. Männistöand and P. Jousilahti, 2007. Body mass
Y. Gozukara, 1992.. “Plasma lipids and their index, waist circumference and waisthip ratio on the
interrelationship in Turkish adults,” Journal of risk of total and type-specific stroke. Arch Intern
Epidemiology and Community Health, 5: 470-476. Med., 167: 1420-7.
30.  The Research Group ATS-RF2 of the Italian  37. Despres, J.P., I. Lemieuxand and D. Prud’homme,
National Research Council, “Distribution of some 2001. Treatment of obesity: need to focus on high
risk factors for atherosclerosis in nine Italian risk abdominally obese patients. BMJ, 322: 716-720.
population samples,” American J. Epidemiol., 1981. 38. Lobo, R.A., 2008. Metabolic syndrome after
113: 338-346. menopause  and  the  role  of  hormones.  Maturitas,
31. MacLean,  D.R.,  A.  Petrasovits,   P.W.   Connelly, 60: 10-18.
M. Joffres, B. O’Connor and J.A. Little, 1999. 39. WHO Global infobase, “Iran: Most recent national
“Plasma lipids and lipoprotein reference values and survey (s) for chronic, non-communicable diseases
the prevalence of dyslipoproteinemia in Canadian risk factors,” https://apps.who.int/infobase/report.
adults. Canadian Heart Health Surveys Research aspx.
Group,” Canadian J. Cardiol., 4: 434-444. 40. Mirmiran, P., F. Mohammadi and  F. Allahverdian
32. Mann, J.I., B. Lewis, J. Shepherd, et al., 1988. “Blood and S. Azizi, 2001. “Measurement of total energy
lipid concentrations and other cardiovascular risk requirement in adults: prospective Tehran Lipid and
factors: distribution, prevalence and detection in Glucose Study, Pajouhandeh,” Journal of Shahid
Britain,” British Medical J., 6638: 1702-1706. Beheshti University of Medical Sci., 6: 157-166
33. Sharifi, F., S.N. Mousavinasab, R. Soruri, M. Saeini (Persian).
and M. Dinmohammadi, 2008. “High prevalence of
low high-density lipoprotein cholesterol
concentrations and other dyslipidemic phenotypes
in an Iranian population,” Metabolic Syndrome and
Related Disorders, 3: 187-195.
